European Hemostats Market: Forecast (2017-2023)

Wednesday, November 22, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Nov. 21, 2017 /PRNewswire/ -- Hemostats are instruments used to reduce or halt bleeding during surgery. These can

be enabled by the time privileged approaches of smearing pressure, stitching the bleeding or using thermal energy devices.

Read the full report:

Bleeding control is a significant factor in surgical

and trauma settings as it reduces the risk of infection, save operative time and reduces the patient stay in hospitals. As surgical procedures evolve to be more refined and non-invasive, the use of fast acting biologically and synthetically derived hemostats, encompassing fibrin sealants, flow able gelatins and adhesives is becoming increasingly prevalent. Some of the consideration parameters for choosing a particular hemostatic agent include efficiency, type of surgery, patient condition and active bleeding tissue versus pooled blood sites and cost.

European hemostats market is comprehended by type, treatment and end users. Based on type the market is categorized into thrombin based hemostats, gelatin based hemostats, collagen based hemostats, oxidized regenerated cellulose based hemostats, combination hemostats and others.

By treatment the market is further segmented into cardiac surgery, vascular procedures, soft tissue reconstructions, spinal procedures, hepatic resection and others. Based on end users the market is categorized into hospitals, surgery centers, nursing homes and others.

European hemostats market is further analyzed on the basis of countries such as: U.K., Ireland, France, Germany, Spain, Italy, Netherlands, Belgium, Austria, Norway, Sweden, Finland, Denmark, Switzerland, Portugal, Rest of Europe.

Sample Companies profiled in this report are:B Braun Melsungen AG (Germany),Gelita Medical GmbH (Germany),Equimedical (Netherlands),Pfizer Inc. (U.S.),Johnson & Johnson Services, Inc. (U.S.),10+.

Increase in number of surgical procedures will propel the growth of the market. Wide range of applications, continuous advancement in product portfolio, technological advancement facilitating the end users and insurance support to manufacturers in promoting tissue sealants are the major driving forces of European hemostats market.

The research methodology opted for this report incorporates initial segregation of the market by type, treatment, end users and countries. This was followed by mining of market volume and revenue of different type of hemostats employed by various end users with respect to countries are considered.

Bottom up approach was then followed for estimating the global market size and its forecast for period 2017 to 2023. The data figures and supporting insights so collated were validated through primary research process by Key Opinion Leaders (KOLs) which comprised of manufacturers, distributors, suppliers, associations and end users.

Read the full report:

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001


View original content:

SOURCE Reportlinker


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store